Search This Blog

Thursday, April 30, 2020

Abiomed EPS beats by $0.01, misses on revenue

Abiomed (NASDAQ:ABMD): Q4 Non-GAAP EPS of $0.98 beats by $0.01; GAAP EPS of $0.70 misses by $0.22.
Revenue of $206.66M (-0.2% Y/Y) misses by $2.92M.
Press Release
https://seekingalpha.com/news/3566775-abiomed-eps-beats-0_01-misses-on-revenue
Posted by at

No comments:

Post a Comment

Note: Only a member of this blog may post a comment.

Subscribe to: Post Comments (Atom)